The American Association for the Study of Liver Diseases recommends a stepwise algorithmic approach, with a detailed medical and family history of liver disease or early-onset neuropsychiatric disease, slit lamp exam, 24-hour urinary copper excretion, and serum ceruloplasmin level, followed by hepatic copper quantification and histological assay. The gene discussed is CP; the disease is liver disorder.